Diabetic Nephrology

Diabetic Diabetic nephropathy (DN) is typically defined by macro albuminuria—that is, a urinary albumin excretion of more than 300 mg in a 24-hour collection—or macro albuminuria and abnormal renal function as represented by an abnormality in serum creatinine, calculated creatinine clearance, or glomerular filteration filtration rate (GFR). Clinically, diabetic nephropathy is characterized by a progressive increase in proteinuria and decline in GFR, hypertension, and a high risk of cardiovascular morbidity and mortality. Diabetic nephropathy is a clinical syndrome characterized by the following: Proteinuria was first recognized in diabetes mellitus in the late 18th century.

  • Diabetic Microvascular Complications, Diabetic Nephropathy
  • Nephropathology and pathogenesis of diabetic nephropathy
  • Contrast nephropathy, uric acid nephropathy
  • Diabetic glomerulosclerosis, IgA nephropathy
  • HIV associated nephropathy
  • Glycemic control, diabetic ketoacidosis

Related Conference of Diabetic Nephrology

April 27-28, 2020

16th World Nephrology Conference

Singapore
April 27-28, 2020

5th World Kidney Congress

Dubai, UAE
June 10-11, 2020

21st Global Nephrologists Annual Meeting

Frankfurt, Germany
September 14-15, 2020

17th Asia Pacific Nephrology Conference

Osaka, Japan
September 14-15, 2020

22nd World Nephrologists Summit

Tokyo, Japan
September 16-17, 2020

15th Nephrology,Renal Medicine & Renal Care

Tokyo, Japan
October 12-13, 2020

24th European Nephrology Conference

Zurich, Switzerland
October 26-27, 2020

3rd International Conference on Nephrology

Dubai, UAE
November 09-10, 2020

International Conference on  Urology and Andrology

Bangkok, Thailand
November 23-24, 2020

World Congress and Expo on Nephrology

Hanoi, Vietnam

Diabetic Nephrology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in